Summary: Eight-year-old Emirati, Maha Abdulla is the only known surviving patient in the UAE suffering from chronic myelogenous leukaemia (CML) which is an uncommon type of cancer of the blood
Haematologists are also experts on cancer of the blood
(leukaemia) and on blood clotting problems such as haemophilia.
Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood
and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) following a blood stem cell transplant had their cancer kept in check longer than patients who received a placebo.
For some types of cancer of the blood
, a bone marrow transplant is the only treatment option.
Among them are hypothyroidism, liver disease and multiple myeloma, an incurable cancer of the blood
Today, the list of presumptive service-connected health problems caused by exposure to Agent Orange and other herbicides includes chloracne (a skin disease), Hodgkin's disease, multiple mycloma to (a cancer of the blood
cells), non-Hodgkin's lymphoma, porphyria cutanea tarda (a skin disease caused by a defective liver enzyme), respiratory cancers (lung, bronchus, larynx, and trachea), soft-tissue sarcoma (cancer of the muscles and tendons), acute and subacute peripheral neuropathy (weakening of the nervous system), prostate cancer, chronic lymphocytic leukemia, and adult-onset (Type 2) diabetes.
Researchers in Sweden followed 16,539 twins for more than 30 years, tracking any allergic conditions they suffered and the development of any cancer of the blood
Last year, the Food and Drug Administration approved the proteasome inhibitor bortezomib (Velcade) for the treatment of multiple myeloma, a cancer of the blood
Paul, 38, from Durham, suffers from chronic lymphocytic leukaemia, a cancer of the blood
that affects 3,000 people in the UK each year.
STI-571 targets a mutant protein in a cancer-causing gene specific to chronic myelogenous leukemia, a cancer of the blood
that strikes more than 4,300 Americans each year.
WASHINGTON, March 2 /PRNewswire/ -- The Food and Drug Administration (FDA) today announced approval of a one-treatment intravenous drug for hairy cell leukemia, a rare, often fatal cancer of the blood
and bone marrow.